On Mar. 28, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to…
On Mar. 27, 2020, in response to the crisis caused by the COVID-19 virus in California and around…
On Mar. 27, 2020, Luminex announced the U.S. Food and Drug Administration (FDA) had issued an Emergency Use…
On Mar. 27, 2020, Abbott announced the U.S. Food and Drug Administration (FDA) had issued Emergency Use Authorization…
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 24, 2020, Windtree Therapeutics announced it will study its proprietary KL4 surfactant to potentially mitigate the…
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
On Mar. 19, 2020, Abbott announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA)…
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…
On Mar. 19, 2020, Mylan announced its continued commitment to do its part in support of public health…
On Mar. 18, 2020, Abbott announced that the the U.S. Food and Drug Administration had issued Emergency Use…
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…
On Mar. 16, 2020, Aimmune Therapeutics announced that the first patients in the U.S. were being treated with…
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
On Mar. 13, 2020, Roche announced the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization…
On Mar. 13, 2020, Thermo Fisher Scientific announced the U.S. Food and Drug Administration (FDA) has issued an emergency…
On Mar. 13, 2020, declared a COVID-related emergency under Section 501(b) of the Stafford Act [18]. Under the…
On Mar. 9, 2020, The U.S. Food and Drug Administration (FDA) approved Ofev (nintedanib) oral capsules to treat…
On Mar. 6, 2020, the U.S. Food and Drug Administration (FDA) approved Isturisa (osilodrostat) oral tablets for adults…
On Mar. 6, 2020, Innovation Pharmaceuticals continues to receive inquiries regarding the potential of Brilacidin, the Company’s novel…
On Mar. 4, 2020, the UW Medicine Clinical Virology Lab announced it had received U.S. Food and Drug…
On Mar. 2, 2020, Mateon Therapeutics reported the company had been evaluating its therapeutic and AI platforms to…
On Feb. 29, 2020, the University of Washington (UW) Medicine Clinical Virology Lab announced it had received U.S….